Literature DB >> 1675666

Conversion of tyrosine hydroxylase to stable and inactive form by the end products.

S Okuno1, H Fujisawa.   

Abstract

We have reported previously that tyrosine hydroxylase in the crude extract from rat striatum exists in the inactive form showing almost no activity at the physiological pH and that the inactive form is produced by the action of the end products of the enzyme, such as dopamine. The incubation of the enzyme with the end products resulted in not only the inactivation but also a remarkable stabilization of the enzyme. Catechols possessing amino groups but no negatively charged groups on the side chains (catecholamine-type catechols) were effective at a concentration as low as 10(-7) M in both the inactivation and stabilization of the enzyme. In contrast, catechols not possessing positively or negatively charged side chains (3,4-dihydroxyphenylethyleneglycol-type catechols) were ineffective at a concentration of 10(-7) M but effective at a concentration of 10(-6) M for both the inactivation and stabilization. Catechols possessing negatively charged groups (3,4-dihydroxyphenylacetic acid-type catechols) were ineffective even at a concentration of 10(-6) M. Thus, the end products of tyrosine hydroxylase appear to serve to keep the enzyme inactive and stable. The reaction mechanism of the conversion of the enzyme from the active/labile form to the inactive/stable form by dopamine was also investigated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675666     DOI: 10.1111/j.1471-4159.1991.tb02098.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

1.  Melatonin: effects on dopaminergic and serotonergic neurons of the caudate nucleus of the striatum of male Syrian hamsters.

Authors:  N A M Alexiuk; J Vriend
Journal:  J Neural Transm (Vienna)       Date:  2006-10-27       Impact factor: 3.575

2.  Regulation of N-terminus-deleted human tyrosine hydroxylase type 1 by end products of catecholamine biosynthetic pathway.

Authors:  A Ota; S Yoshida; T Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  Cloning and expression of human placental L-Dopa decarboxylase.

Authors:  Maria-Zaharenia Siaterli; Dido Vassilacopoulou; Emmanuel G Fragoulis
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

Review 4.  Tyrosine hydroxylase and Parkinson's disease.

Authors:  J Haavik; K Toska
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

5.  Purification and characterization of the blue-green rat phaeochromocytoma (PC12) tyrosine hydroxylase with a dopamine-Fe(III) complex. Reversal of the endogenous feedback inhibition by phosphorylation of serine-40.

Authors:  K K Andersson; C Vassort; B A Brennan; L Que; J Haavik; T Flatmark; F Gros; J Thibault
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

Review 6.  Role of N-terminus of tyrosine hydroxylase in the biosynthesis of catecholamines.

Authors:  A Nakashima; N Hayashi; Y S Kaneko; K Mori; E L Sabban; Toshiharu Nagatsu; A Ota
Journal:  J Neural Transm (Vienna)       Date:  2009-04-25       Impact factor: 3.575

7.  1,2,3,4-Tetrahydro-2-methyl-4,6,7-isoquinolinetriol inhibits tyrosine hydroxylase activity in rat striatal synaptosomes.

Authors:  J Liptrot; D Holdup; O Phillipson
Journal:  J Neural Transm Gen Sect       Date:  1994

8.  Detection, purification and identification of an endogenous inhibitor of L-Dopa decarboxylase activity from human placenta.

Authors:  Alice-Georgia Vassiliou; Emmanuel G Fragoulis; Dido Vassilacopoulou
Journal:  Neurochem Res       Date:  2008-11-13       Impact factor: 3.996

9.  Stable preparations of tyrosine hydroxylase provide the solution structure of the full-length enzyme.

Authors:  Maria T Bezem; Anne Baumann; Lars Skjærven; Romain Meyer; Petri Kursula; Aurora Martinez; Marte I Flydal
Journal:  Sci Rep       Date:  2016-07-27       Impact factor: 4.379

10.  Positive symptom phenotypes appear progressively in "EDiPS", a new animal model of the schizophrenia prodrome.

Authors:  Alice Petty; Xiaoying Cui; Asad Ali; Zilong Du; Sunil Srivastav; James P Kesby; Deniz Kirik; Oliver Howes; Darryl Eyles
Journal:  Sci Rep       Date:  2021-02-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.